Sonder Capital's Second Fund: A New Era for Healthcare Innovation

Sonder Capital, a prominent venture capital firm dedicated to transforming healthcare, has announced the closure of its second fund, named Futures II. This significant development not only showcases the firm’s commitment to advancing healthcare technology but also emphasizes its collaboration with major healthcare systems such as Mayo Clinic and Sutter Health.

The announcement, made on March 24, 2026, reflects a powerful union between venture capital and frontline healthcare delivery. According to Kate Garrett, Managing Partner at Sonder Capital, the involvement of respected healthcare institutions aims to enhance patient care through innovative technologies. "Through our second fund, we'll continue enabling the next wave of companies and healthcare technologies reshaping medicine," she stated. By collaborating with these institutions, Sonder Capital strengthens its capacity to support startups with invaluable insights from those who deliver care directly, ensuring that innovations translate into genuine improvements in patient experiences.

Futures II is anchored by an ambitious investment thesis focused on AI-enabled medical robotics and minimally invasive therapies. This fund is poised to support companies that are pioneering new care pathways and business models, revolutionizing how healthcare is delivered and who can deliver it. The vision is not just to treat conditions but also to redefine the spaces in which treatment occurs.

Dr. Fred Moll, a founding partner of Sonder Capital, expressed the transformative potential of medical robotics integrated with AI. "Medical robotics has already transformed what's possible in the operating room—and we're now entering the next chapter," he remarked. As healthcare systems worldwide grapple with increasing demands for better patient outcomes, the infusion of AI is anticipated to significantly enhance performance and automation across various care pathways. This evolution promises to benefit not only patients but also clinicians and health systems at large.

Sonder Capital's team is composed of seasoned investors and pioneering healthcare innovators, recognized for their impressive track record in building and funding organizations that have greatly impacted global healthcare. Some of their notable past endeavors include groundbreaking companies such as Intuitive Surgical, Guidant Corporation, and Shockwave Medical.

The extensive network of limited partners backing Sonder Capital brings together industry leaders and high-net-worth individuals who share a common objective: investing in transformative healthcare solutions. Since its co-founding in 2019 by healthcare visionaries Jay Watkins and Dr. Fred Moll, Sonder has garnered significant attention and respect in the venture capital landscape.

With the establishment of Futures II, Sonder Capital gears up to ignite a new wave of innovation in the healthcare sector. Not only does the firm look to refine existing care models, but it also aims to unlock potential pathways for patient treatment that were previously unattainable. As healthcare continues to evolve in response to technological advancements, the integration of AI in medical robotics and related fields signals a future where patients can receive care that is both efficient and highly personalized.

In summary, Sonder Capital's Futures II fund stands as a testament to its unwavering commitment to revolutionizing healthcare. By investing in technologies that advance patient care access, quality, and overall experience, the firm is poised to play a pivotal role in shaping the future of medicine. With major healthcare systems alongside, the outlook for this new venture is promising, representing not just a funding milestone but a strategic push toward a healthier future for all.

For further information about Sonder Capital and its initiatives, visit their website at www.sondercapital.com.